IDiyas

For the Inventor, By the Inventor

Craigavon, United Kingdom

Magnus Widegren

USPTO Granted Patents = 12

Average Co-Inventor Count = 13.0

ph-index = 5

Forward Citations = 46(Granted Patents)


Company Filing History:

goldMedal12 out of 459 
 
Codexis, Inc.
 patents

Years Active: 2016-2025

Loading Chart...
12 patents (USPTO):Explore Patents
1. 12344866 - Biocatalysts and methods for the synthesis of armodafinil (2025-07-01),
2. 11384343 - Biocatalysts and methods for the synthesis of armodafinil (2022-07-12),
3. 10961517 - Biocatalysts and methods for the synthesis of armodafinil (2021-03-30),
4. 10781429 - Biocatalysts and methods for the synthesis of armodafinil (2020-09-22),
5. 10557126 - Polynucleotides encoding cyclohexanone monooxygenases (2020-02-11),
6. 10400223 - Biocatalysts and methods for the synthesis of armodafinil (2019-09-03),
7. 10087426 - Polynucleotides encoding cyclohexanone monooxygenases (2018-10-02),
8. 9938509 - Biocatalysts and methods for the synthesis of armodafinil (2018-04-10),
9. 9765306 - Biocatalysts and methods for the synthesis of armodafinil (2017-09-19),
10. 9528095 - Biocatalysts and methods for the synthesis of armodafinil (2016-12-27),
11. 9365835 - Biocatalysts and methods for the synthesis of armodafinil (2016-06-14),
12. 9267159 - Biocatalysts and methods for the synthesis of armodafinil (2016-02-23),

Title: Innovator Spotlight: Magnus Widegren - Pushing Boundaries in Biocatalysis

Introduction:

Magnus Widegren, a prolific inventor based in Craigavon, GB, has become a leading figure in the world of biocatalysis and pharmaceutical synthesis. With a remarkable portfolio of 11 patents to his name, Widegren's contributions have been instrumental in the development of cutting-edge solutions in the field.

Latest Patents:

Widegren's latest patents showcase his expertise in the synthesis of armodafinil, a key pharmaceutical compound. These patents revolve around non-naturally occurring polypeptides that play a crucial role in the biocatalytic conversion of specific compounds to armodafinil and its intermediates. This innovation paves the way for more efficient and sustainable methods in drug synthesis.

Career Highlights:

Currently affiliated with Codexis, Inc., a prominent player in the biotechnology industry, Magnus Widegren continues to drive innovation and excellence in his work. His dedication to pushing the boundaries of biocatalysis has earned him recognition as a leading expert in the field.

Collaborations:

Widegren's work has not been done in isolation. He has collaborated closely with esteemed colleagues such as Ee Lui Ang and Oscar Alvizo. Together, they have collectively contributed to the advancement of biocatalysis and pharmaceutical synthesis, setting new standards of excellence in the industry.

Conclusion:

In conclusion, Magnus Widegren's exceptional talent and relentless pursuit of innovation have made him a trailblazer in the field of biocatalysis. His patents and collaborations stand as a testament to his dedication to pushing the boundaries of what is possible in pharmaceutical synthesis. The impact of his work reverberates throughout the industry, shaping the future of biotechnology and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…